In addition, lncRNA HISLA siRNA-treated exosomes led to the increased expression of E-cadherin and downregulation of N-cadherin, Vimentin, and VEGF, which meant that silencing of HISLA in TAM-exo suppressed the EMT potential of BC cells (Figure 4(h)). The gene discussed is CDH1; the disease is breast cancer.